1)川崎富作:指趾の特異的落屑を伴う小児の急性熱性皮膚粘膜淋巴腺症候群:自験例50例の臨床的観察.アレルギー 16:178-222,1967
2)Landing BH, Larson EJ:Are infantile periarteritis nodosa with coronary artery involvement and fatal mucocutaneous lymph node syndrome the same? Comparison of 20 patients from North America with patients from Hawaii and Japan. Pediatrics 59:651-662,1977
3)赤城邦彦:病因説の変遷.小児科臨床ピクシス9川崎病のすべて(総編:五十嵐隆,専門編:石井正浩),中山書店,pp26-29,2009
4)Onouchi Y, Gunji T, Burns JC, et al:ITPKC functional polymorphism associated with Kawasaki disease susceptibility and formation of coronary artery aneurysms. Nat Genet 40:35-42,2008
5)厚生労働省川崎病研究班川崎病診断の手引き,改訂5版,日本小児科学会雑誌 106:836-837,2002
6)上村茂:不全型の特徴と診断.小児科臨床ピクシス9川崎病のすべて(総編:五十嵐隆,専門編:石井正浩),中山書店,pp62-65,2009
7)上原里程,屋代真弓,中村好一,他:川崎病容疑例(狭義の不全型)の疫学的特徴.日本小児科学会雑誌 114:497-502,2010
8)Newburger JW, Takahashi M, Gerber MA, et al:Diagnosis, treatment, and long-term management of Kawasaki disease: a statement for health professionals from the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease. Council on Cardiovascular Disease in the Young, American Heart Association. Pediatrics 114:1708-1733,2004
9)Uehara R, Igarashi H, Yashiro M, et al:Kawasaki disease patients with redness or crust formation at the Bacille Calmette-Guérin inoculation site. Pediatr Infect Dis J 29:430-433,2010
10)Furukawa S, Matsubara T, Jujoh K, et al:Peripheral blood monocyte/macrophages and serum tumor necrosis factor in Kawasaki disease. Clin Immunol Immunopathol 48:247-251,1988
11)Lin CY, Lin CC, Hwang B, et al:Serial changes of serum interleukin-6, interleukin-8, and tumor necrosis factor alpha among patients with Kawasaki disease. J Pediatr 121:924-926,1992
12)Hirao J, Hibi S, Andoh T, et al:High levels of circulating interleukin-4 and interleukin-10 in Kawasaki disease. Int Arch Allergy Immunol 112:152-156,1997
13)Furukawa S, Matsubara T, Umezawa Y, et al:Serum levels of p60 soluble tumor necrosis factor receptor during acute Kawasaki disease. J Pediatr 124:721-725,1994
14)Fujiwara H, Hamashima Y:Pathology of the heart in Kawasaki disease. Pediatrics 61:100-107,1978
15)赤城邦彦:川崎病冠動脈病変の発症機序に関する一考察―病理所見の見直しと血管栄養血管(脈管の脈管)の重要性について.小児科臨床 63:1991-1997,2010
16)Naoe S, Takahashi K, Masuda H, et al:Kawasaki disease. With particular emphasis on arterial lesions. Acta Pathol Jpn 41:785-797,1991
17)Galeotti C, Bayry J, Kone-Paut I, et al:Kawasaki disease. aetiopathogenesis and therapeutic utility of intravenous immunoglobulin. Autoimmun Rev 9:441-448,2010
18)Ichiyama T, Ueno Y, Hasegawa M, et al:Intravenous immunoglobulin inhibits NF-kappaB activation and affects Fcgamma receptor expression in monocytes/macrophages. Naunyn Schmiedebergs Arch Pharmacol 369:428-433,2004
19)Matsuda A, Morita H, Unno H, et al:Anti-inflammatory effects of high-dose IgG on TNF-α-activated human coronary artery endothelial cells. Eur J Immunol 42:2121-2131,2012
20)Terai M, Jibiki T, Harada A, et al:Dramatic decrease of circulating levels of monocyte chemoattractant protein-1 in Kawasaki disease after gamma globulin treatment. J Leukoc Biol 65:566-572,1999
21)Yoshimura K, Tatsumi K, Iharada A, et al:Increased nitric oxide production by neutrophils in early stage of Kawasaki disease. Eur J Pediatr 168:1037-1041,2009
22)Burns JC, Best BM, Mejias A, et al:Infliximab treatment of intravenous immunoglobulin -resistant Kawasaki disease. J Pediatr 153:833-838,2008
23)Hirono K, Kemmotsu Y, Wittkowski H, et al:Infliximab reduces cytokine-mediated inflammation but does not suppress cellular infiltration of the vessel wall in refractory Kawasaki disease. Pediatr Res 65:696-701,2009
24)石川順一,鹿間芳明,赤城邦彦:けいれん,DIC,手指壊疽性変化,僧帽弁腱索断裂,一過性冠動脈病変合併の重症川崎病の1乳児例. 小児感染免疫 24:163-170,2012